BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 21031597)

  • 1. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: Importance of copy neutral LOH.
    Garcia-Linares C; Fernández-Rodríguez J; Terribas E; Mercadé J; Pros E; Benito L; Benavente Y; Capellà G; Ravella A; Blanco I; Kehrer-Sawatzki H; Lázaro C; Serra E
    Hum Mutat; 2011 Jan; 32(1):78-90. PubMed ID: 21031597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of loss of heterozygosity in neurofibromatosis type 1-associated plexiform neurofibromas.
    Steinmann K; Kluwe L; Friedrich RE; Mautner VF; Cooper DN; Kehrer-Sawatzki H
    J Invest Dermatol; 2009 Mar; 129(3):615-21. PubMed ID: 18800150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic NF1 mutational spectrum in benign neurofibromas: mRNA splice defects are common among point mutations.
    Serra E; Ars E; Ravella A; Sánchez A; Puig S; Rosenbaum T; Estivill X; Lázaro C
    Hum Genet; 2001 May; 108(5):416-29. PubMed ID: 11409870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis Type 1 Cohort with Tibial Pseudarthrosis.
    Margraf RL; VanSant-Webb C; Sant D; Carey J; Hanson H; D'Astous J; Viskochil D; Stevenson DA; Mao R
    J Mol Diagn; 2017 May; 19(3):468-474. PubMed ID: 28433079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors.
    Upadhyaya M; Han S; Consoli C; Majounie E; Horan M; Thomas NS; Potts C; Griffiths S; Ruggieri M; von Deimling A; Cooper DN
    Hum Mutat; 2004 Feb; 23(2):134-146. PubMed ID: 14722917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene.
    Däschner K; Assum G; Eisenbarth I; Krone W; Hoffmeyer S; Wortmann S; Heymer B; Kehrer-Sawatzki H
    Biochem Biophys Res Commun; 1997 May; 234(2):346-50. PubMed ID: 9177273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic loss of wild type NF1 allele in neurofibromas: Comparison of NF1 microdeletion and non-microdeletion patients.
    De Raedt T; Maertens O; Chmara M; Brems H; Heyns I; Sciot R; Majounie E; Upadhyaya M; De Schepper S; Speleman F; Messiaen L; Vermeesch JR; Legius E
    Genes Chromosomes Cancer; 2006 Oct; 45(10):893-904. PubMed ID: 16830335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1.
    Eisenbarth I; Beyer K; Krone W; Assum G
    Am J Hum Genet; 2000 Feb; 66(2):393-401. PubMed ID: 10677298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of NF1 somatic mutations in cutaneous neurofibromas from patients with high tumor burden.
    Thomas L; Kluwe L; Chuzhanova N; Mautner V; Upadhyaya M
    Neurogenetics; 2010 Oct; 11(4):391-400. PubMed ID: 20358387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.
    Upadhyaya M; Spurlock G; Kluwe L; Chuzhanova N; Bennett E; Thomas N; Guha A; Mautner V
    Neurogenetics; 2009 Jul; 10(3):251-63. PubMed ID: 19221814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies.
    Stephens K; Weaver M; Leppig KA; Maruyama K; Emanuel PD; Le Beau MM; Shannon KM
    Blood; 2006 Sep; 108(5):1684-9. PubMed ID: 16690971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell PCR performed with neurofibroma Schwann cells reveals the presence of both alleles of the neurofibromatosis type 1 (NF1) gene.
    Stark M; Assum G; Krone W
    Hum Genet; 1995 Nov; 96(5):619-23. PubMed ID: 8530015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas.
    Serra E; Puig S; Otero D; Gaona A; Kruyer H; Ars E; Estivill X; Lázaro C
    Am J Hum Genet; 1997 Sep; 61(3):512-9. PubMed ID: 9326316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitotic recombination of chromosome arm 17q as a cause of loss of heterozygosity of NF1 in neurofibromatosis type 1-associated glomus tumors.
    Stewart DR; Pemov A; Van Loo P; Beert E; Brems H; Sciot R; Claes K; Pak E; Dutra A; Lee CC; Legius E
    Genes Chromosomes Cancer; 2012 May; 51(5):429-37. PubMed ID: 22250039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic recombination effects homozygosity for NF1 germline mutations in neurofibromas.
    Serra E; Rosenbaum T; Nadal M; Winner U; Ars E; Estivill X; Lázaro C
    Nat Genet; 2001 Jul; 28(3):294-6. PubMed ID: 11431704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor and Constitutional Sequencing for Neurofibromatosis Type 1.
    Tong S; Devine WP; Shieh JT
    JCO Precis Oncol; 2022 May; 6():e2100540. PubMed ID: 35584348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1.
    McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS
    Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.
    Anastasaki C; Dahiya S; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47574-47585. PubMed ID: 28548933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical neurofibromas in neurofibromatosis type 1 are premalignant tumors.
    Beert E; Brems H; Daniëls B; De Wever I; Van Calenbergh F; Schoenaers J; Debiec-Rychter M; Gevaert O; De Raedt T; Van Den Bruel A; de Ravel T; Cichowski K; Kluwe L; Mautner V; Sciot R; Legius E
    Genes Chromosomes Cancer; 2011 Dec; 50(12):1021-32. PubMed ID: 21987445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.